Health Affairs December 24, 2025
Kristi Martin, Rachel Sachs

Editor’s Note

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analysis of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress.

On Friday, December 19, the Centers for Medicare & Medicaid Services (CMS) proposed two models aiming to implement international reference pricing approaches for drugs under Medicare: the GLOBE (Global Benchmark for Efficient Drug Pricing) Model in Medicare Part B, and the GUARD (Guarding U.S. Medicare Against Rising Drug Costs) Model in Medicare Part D. As proposed, both models would be mandatory for any...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Reengineering ACOs To Make Medicare Competitive
Major CMS‑Recognized Hospital Types
No Surprises disputes increasing even as arbiters catch up, CMS says
CMS proposes nearly flat Medicare Advantage payments for 2027: 6 notes
The Persistent Rising Tide of U.S. Health Care Spending

Share Article